Renaud Gaujoux

Title: Renaud Gaujoux: An Inventor in Inflammatory Bowel Disease Research

Introduction

Renaud Gaujoux is an inventor associated with research on immune-cell patterns and treatment response in inflammatory bowel disease. His patent record includes 1 patent, and the supplied information connects his work with Cape Town, South Africa.

Latest Patents

Gaujoux’s patent, “Infiltrating immune cell proportions predict anti-TNF response in colon biopsies,” describes methods for predicting whether a person with inflammatory bowel disease may respond to a tumor necrosis factor-alpha inhibitor. The methods analyze the frequency of one or more immune-cell subpopulations in a tissue biopsy. The patent also describes approaches for selecting treatment and kits for assessing responsiveness to TNF-alpha inhibitor therapy.

Career Highlights

The organizations associated with Gaujoux’s career include Technion Research & Development Foundation Ltd. and Leland Stanford Junior University. The patent reflects an effort to use biopsy-based immune-cell measurements to inform treatment decisions.

Collaborations

Gaujoux’s listed coworkers include Shai S. Shen-Orr and Naama Maimon. Their shared research context is reflected in the patent’s focus on immune-cell proportions and anti-TNF treatment response.

Conclusion

Renaud Gaujoux’s patent applies immune-cell analysis to the challenge of predicting treatment response in inflammatory bowel disease, linking biomedical research with potential clinical decision-making.